Kubota Pharmaceutical Holdings Co. Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-676.00
-1,332.00
-1,489.00
-2,015.00
-2,616.00
-2,437.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
23.00
-63.00
-73.00
-137.00
-23.00
145.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-581.00
-1,188.00
-1,321.00
-2,069.00
-2,495.00
-2,169.00
Cash Flow from Investing Activities
-5.00
-49.00
-59.00
488.00
3,544.00
260.00
Cash Flow from Financing Activities
1,065.00
-88.00
96.00
1,446.00
171.00
453.00
Net Cash Inflow / Outflow
463.00
-1,312.00
-1,281.00
71.00
1,443.00
-1,658.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-15.00
13.00
3.00
206.00
223.00
-204.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Kubota Pharmaceutical Holdings Co. Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
-676.253
827.155
-1,503.00
-181.76%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
23.554
76.047
-53.00
-69.03%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-581.138
704.782
-1,285.00
-182.46%
Cash Flow from Investing Activities
-5.514
-71.304
66.00
92.27%
Cash Flow from Financing Activities
1065.666
-411.037
1,476.00
359.26%
Net Cash Inflow / Outflow
463.707
222.44
241.00
108.46%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-15.307
-0.001
-15.00
-1530600.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 51.10% vs 10.03% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-581.14
-1,188.51
51.10%






